#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Prolymphocytic leukaemia Pneumonia Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Squamous cell carcinoma of the oral cavity Ductal adenocarcinoma of pancreas Chondrosarcoma B-cell small lymphocytic lymphoma recurrent Encephalopathy neonatal CDKL5 deficiency disorder Diabetes insipidus Pemphigoid Ichthyosis Acquired C1 inhibitor deficiency Chronic graft versus host disease in skin Haemophilia B with anti factor IX More trials…

    Learn about Rare Diseases

    Systemic mastocytosis – Trials in Disease Mantle cell lymphoma stage II – Treatment Optic glioma – Life with Disease Systemic mastocytosis – Basic Information Fabry’s disease – Diagnostics Testicular leiomyosarcoma – Diagnostics Nephrotic syndrome Proteus syndrome – Trials in Disease Mast cell activation syndrome – Treatment Hepatic angiosarcoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Avalotcagene Ontaparvovec Fingolimod Ubiquinol Pitavastatin Calcium Treosulfan Vancomycin Amy109 Ondansetron Hydrochloride GAXILOSE Teclistamab Sasanlimab Cart45Ra-Nkg2D Cells Micafungin TX000045 Ceftriaxone Sodium Avelumab HTL0022537 Dextromethadone Hydrochloride Oric-114 Calcipotriol More therapies…

    Learn about Your Condition

    Adenomatous polyposis coli Leiomyosarcoma recurrent Myelofibrosis Peripheral artery angioplasty Arteriosclerosis Exposure via breast milk Optic atrophy Noonan syndrome Vulval cancer recurrent Advanced systemic mastocytosis Eclampsia Seasonal allergy Lip and/or oral cavity cancer Stress urinary incontinence Pain in extremity More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Retinopathy of prematurity

  • Study on Oral Propranolol for Preventing Severe Retinopathy in Premature Infants

    Recruiting

    2 1 1
    Investigated Diseases:
    • Retinopathy of prematurity
    Investigated Drugs:
    • Propranolol Hydrochloride
    Germany

  • Intranasal Dexmedetomidine for Pain Relief During Retinopathy of Prematurity Screening in Preterm Infants <30 Weeks Gestation Using Standard Drug Combination

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Retinopathy of prematurity
    Investigated Drugs:
    • Phenylephrine Hydrochloride
    • Dexmedetomidine
    • Oxybuprocaine Hydrochloride
    Norway

  • Study on Automatic Oxygen Control for Extremely Preterm Infants Using Oxygen PH.EUR.

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Death neonatal
    • Infantile apnoea
    • Necrotising enterocolitis neonatal
    Investigated Drugs:
    • Oxygen Ph.eur.
    Germany

  • Long-Term Study on Aflibercept for Retinopathy of Prematurity in Children

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Retinopathy of prematurity
    Investigated Drugs:
    • Aflibercept
    Bulgaria Romania

  • Long-Term Study on Aflibercept for Retinopathy of Prematurity in Infants

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Retinopathy of prematurity
    Investigated Drugs:
    • Aflibercept
    Belgium Bulgaria Czechia Greece Italy Portugal +4

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!